L Lashev, D Pashov, I Kanelov
Index: Zentralbl. Veterinarmed. A 42(3) , 201-8, (1995)
Full Text: HTML
Comparative studies on some selected pharmacokinetic parameters of rolitetracycline (effective antimicrobial activity levels) in sheep, pigs, rabbits, chickens and pigeons were carried out after intravenous administration of the drug at a dose of 5 mg/kg. The results revealed that a two-compartment open model was usually optimal. Interspecies differences in the rate (alpha) and the volume of distribution (Vda), the area under the serum concentration time curve (AUC) and the total body clearance (ClB) were small. The values of the elimination half-life (t1/2 beta) found in sheep, pigs, rabbits, chickens and pigeons were 1.51, 3.06, 2.18, 4.33 and 2.51 h respectively. These results and data in mice, rabbits and man taken from literature were analysed to determine any correlation to body mass (W). The log of the elimination half-life values (log t1/2 beta) of rolitetetracycline revealed a significant correlation with log values of (W) between animal species. This relationship was described by the equation t1/2 beta = 1.27.W0.29 (r = 0.93, P < 0.01, n = 5) for mammal species and t1/2 beta = 1.81.W0.24 (r = 0.78, P < 0.05, n = 7) for mammal and bird species.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Rolitetracycline
CAS:751-97-3 |
C27H33N3O8 |
Reversed-phase high-performance liquid chromatography couple...
2008-06-27 [J. Chromatogr. A. 1195(1-2) , 107-16, (2008)] |
Sclerotherapy for hydroceles.
1990-05-01 [J. Urol. 143(5) , 940-3, (1990)] |
Trichloroacetic acid in Norway spruce/soil-system. II. Distr...
2004-07-01 [Chemosphere 56(4) , 327-33, (2004)] |
Disruption of pathologic amyloid beta-protein fibril assembl...
2001-07-01 [Amyloid 8 Suppl 1 , 20-7, (2001)] |
Combined effects of high doses of rolitetracycline and testo...
1986-04-01 [Arch. Int. Pharmacodyn. Ther. 280(2) , 324-8, (1986)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved